Canopy Growth climbs today: Key reasons behind the rally

Traders Union
All News
Financial News
Canopy Growth rises 3.70% to $1.12

Highlights

Canopy Growth reported Q3 FY2026 net revenue of C$90.4 million and a narrowed net loss of C$62.6 million, citing improved sales execution and cost controls.
The company boosted its cash position to C$371.3 million, reduced long-term debt to C$225.0 million, and affirmed the MTL Cannabis acquisition will close this quarter after recapitalization extended certain debt maturities to 2031.
CGC trades at $1.12 below its MA-20, MA-50, and MA-200 with ongoing bearish momentum; resistance is at $1.21, while oversold signals suggest potential stabilization.

Narrowing losses and debt reduction as recapitalization supports deal progress

Canopy Growth reported its Q3 fiscal 2026 results on February 6, 2026, posting net revenue of C$90.4 million and a net loss of C$62.6 million, while increasing its cash position to C$371.3 million and reducing long-term debt to C$225.0 million. The narrowing loss and improved adjusted EBITDA reflect better sales execution and cost controls. Management also confirmed that the acquisition of MTL Cannabis remains on track for closing this quarter, supported by the recent strategic recapitalization extending certain debt maturities to 2031.

Anton Kharitonov, expert at Traders Union, sees Canopy Growth Corp continuing to face strong bearish momentum. He notes that the stock trades below all key moving averages, confirming technical weakness in both short and long terms. Tight forecast ranges and low upside probabilities reflect low confidence from market participants. Fundamental improvements in debt and cash management have not yet translated into stronger price action or sentiment. "Persistent downside risk and lack of clear trend confirmation mean caution remains the only sensible stance here," he says.

Viktoras Karapetjanc, expert at Traders Union, highlights Canopy's strategic recapitalization and debt extension as signals of constructive progress. He points out that narrowing losses, improved adjusted EBITDA, and the pending MTL Cannabis acquisition provide a platform for future growth initiatives. Karapetjanc views the current oversold technical readings as laying groundwork for recovery. "This market setup favors patient investors, as a bullish structure can reassert itself once consolidation gives way to fresh catalysts," he says.

Parshwa Turakhiya, analyst, observes buyers gaining ground intraday despite weak overall momentum for Canopy Growth. He finds the oversold readings on daily oscillators suggest that short-term bounces are possible, with volatility clustering near resistance. Turakhiya believes sentiment remains fragile, but sees range-bound trading as an opportunity for nimble traders. "I see potential for quick tactical plays above $1.14 if intraday strength persists, even though trend traders should remain cautious," he says.

Weak daily momentum as intraday recovery faces longer-term resistance

Momentum signals remain weak, with MACD suggesting bearish pressure and a neutral ADX value reflecting a lack of clear trend strength. Daily oscillators show the stock as oversold based on RSI, Stoch RSI, and CCI, while BBP and intraday dynamics show buyers gaining ground today: the price is up 3.70% to $1.12 with no gap at the open, currently trading near the session’s high of $1.14 within a moderate volatility range, indicating strength toward session highs. However, the divergence between weak daily momentum and strong intraday recovery signals means recovery attempts lack broad confirmation from longer timeframes.

Last time, analysts noted that Canopy Growth Corporation continued to trade below its key short- and long-term moving averages, with technical indicators signaling ongoing bearish momentum and oversold conditions. Despite some signs of intraday buying interest, the stock faces significant resistance and is likely to remain range-bound with limited near-term upside potential.

Source of Data: CGC Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.